Abbott Laboratories vs. Viatris Inc. Common Stock
Abbott Laboratories (ABT) comes out ahead, leading on 6 of 9 compared factors.
Size & Scale
| ABT | VTRS | |
|---|---|---|
| Market Cap | $175.27 billion | $20.48 billion |
| Revenue (TTM) | $46.59 billion | $14.74 billion |
| Net Income (TTM) | $5.42 billion | $-410,700,000 |
ABT leads on 3 of 3 size & scale factors.
Valuation
| ABT | VTRS | |
|---|---|---|
| P/E Ratio | 32.78 | — |
| Price / Book | 3.39 | 1.44 |
| Price / Sales | 3.76 | 1.39 |
VTRS leads on 2 of 2 valuation factors.
Profitability
| ABT | VTRS | |
|---|---|---|
| Net Margin | 11.65% | -2.79% |
| Return on Equity | 10.48% | -2.88% |
ABT leads on 2 of 2 profitability factors.
Dividend
| ABT | VTRS | |
|---|---|---|
| Dividend Yield | 2.49% | 2.63% |
| Payout Ratio | 81.55 | — |
VTRS leads on 1 of 1 dividend factors.
Risk & Sentiment
| ABT | VTRS | |
|---|---|---|
| Short Interest | 0.57% | 4.03% |
ABT leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, VTRS overview, VTRS financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.